Skip to main content
. Author manuscript; available in PMC: 2026 Oct 18.
Published in final edited form as: J Am Coll Cardiol. 2026 Apr 14;87(14):1798–1813. doi: 10.1016/j.jacc.2026.01.087

TABLE 1.

Sample Characteristics

Overall (N = 16,937) Screened (n = 7,989) Control (n = 8,948)
Age, y 74.7 ± 7.0 74.6 ± 6.9 74.8 ± 7.1

Race
 White 13,985 (83) 6,577 (82) 7,408 (83)
 Black 863 (5.1) 436 (5.5) 427 (4.8)
 Hispanic 369 (2.2) 196 (2.5) 173 (1.9)
 Other 1,404 (8.3) 639 (8.0) 765 (8.5)
 Unknown 316 (1.9) 141 (1.8) 175 (2.0)

Sex
 Female 9,654 (57) 4,624 (58) 5,030 (56)
 Male 7,283 (43) 3,365 (42) 3,918 (44)

Height, cm 164.8 ± 10.7 164.9 ± 10.8 164.8 ± 10.7

Weight, kg 76.9 ± 17.8 76.7 ± 17.7 77.1 ± 17.8

Systolic blood pressure, mm Hg 131.1 ± 16.4 131.3 ± 16.2 130.9 ± 16.6

Diastolic blood pressure, mm Hg 73.9 ± 8.7 74.4 ± 8.5 73.4 ± 8.8

Current smoker 856 (5.1) 367 (4.6) 489 (5.5)

Primary care visits in preceding year 5.2 ± 5.2 5.0 ± 5.1 5.5 ± 5.4

Use of antihypertensive medication 13,427 (79) 6,308 (79) 7,119 (80)

Diabetes 4,707 (28) 2,220 (28) 2,487 (28)

History of myocardial infarction 1,866 (11) 893 (11) 973 (11)

History of heart failure 2,648 (16) 1,257 (16) 1,391 (16)

CHARGE-AF scorea 13.7 ± 0.99 13.6 ± 0.98 13.7 ± 1.00

ECG-AI scorea −0.57 ± 0.75 −0.59 ± 0.75 −0.55 ± 0.76

CH-AI scorea 4.6 ± 0.79 4.6 ± 0.78 4.6 ± 0.79

Values are mean ± SD or n (%).

a

Scores can be converted to 2-y risk of AF in VITAL-AF as follows: CHARGE-AF: 1 – 0.9627745exp(ΣβX−13.65969); ECG-AI: 1 – 0.9640965exp(ΣβX+0.5710836); CH-AI: 1 – 0.9662516 exp(ΣβX−4.59939), where ΣβX refers to the listed score value.

AF = atrial fibrillation; CH-AI = Cohorts for Aging Research in Genomic Epidemiology-Atrial Fibrillation plus electrocardiogram-based artificial intelligence; CHARGE-AF = Cohorts for Aging Research in Genomic Epidemiology-Atrial Fibrillation; ECG-AI = electrocardiogram-based artificial intelligence.